Clinical Trial Update: The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes. [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of DWP16001 in combination with metformin in patients with type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• DWP16001
• metformin (metformin)

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: T2DM (Type 2 Diabetes Mellitus) | Phase 3 | Status: COMPLETED